Latest 5 articles from heartwire
- Sen Grassley questions top medical schools about ghostwriting
Nov 20, 2009 13:15 EDT - Stroke incidence related to PCI steady over 15 years
Nov 20, 2009 13:00 EDT - ALLHAT investigators report 10-year follow-up and stand by diuretics as first step antihypertensive treatment
Nov 19, 2009 14:00 EDT - Oral anticoagulants REDEEMed? Daily dabigatran "safe" with dual antiplatelets after MI
Nov 19, 2009 11:00 EDT - EFFECT: Public reporting of hospital performance improves quality of care?
Nov 19, 2009 10:00 EDT
November 20, 2009
LATEST PODCAST
Episode #16: Special AHA wrap-up: ARBITER 6-HALTS, CHAMPION, ticagrelor in PLATO STEMI subanalysis, FAIR-HF, HEAAL, FDA alert on clopidogrel-PPI interaction, ACC/AHA update guidelines for STEMI and PCI
Please note that the audio will stop and restart at the beginning of the file when submitting a comment.
Veuillez notez que le fichier audio s’arrête et recommence au début lorsqu’un commentaire est publié.
Reviewing the week ending November 20, 2009, we highlight the following heartwire articles from the Scientific Sessions of the American Heart Association:
- ACC/AHA focused update of guidelines for STEMI, PCI
- Cardiologists shocked by new FDA alert on clopidogrel-PPI interaction
- HEAAL: High-dose trumps low-dose ARB for heart failure in the ACE-inhibitor intolerant
- FAIR-HF: Symptom improvement, functional gains follow correction of iron deficiency in heart failure
- Good news continues for ticagrelor in PLATO STEMI subanalysis
- CHAMPION: Negative trials but some positive angles for cangrelor?
- ARBITER 6-HALTS: HDL raising with niacin superior to ezetimibe
Join us for an audio recap of the news that is important to cardiologists this week.
Previous postsBillets précédents
Also from theheart.org
About This week in cardiology from heartwire
Published each Friday, this podcast delivers the week's five most popular articles in audio format. On the go? Take heartwire with you and stay on top of the latest in cardiology news, wherever your week takes you.

